Recent BHVN News
- Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity • PR Newswire (US) • 11/25/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:16:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:11:56 PM
- Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments • PR Newswire (US) • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 08:18:10 PM
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 10/02/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/01/2024 08:06:51 PM
- Biohaven Announces Pricing of $250 Million Public Offering of Common Shares • PR Newswire (US) • 10/01/2024 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/30/2024 09:29:09 PM
- Biohaven Announces Proposed Public Offering of Common Shares • PR Newswire (US) • 09/30/2024 08:05:00 PM
- Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine • PR Newswire (US) • 09/30/2024 11:30:00 AM
- Visa Faces Monopoly Lawsuit; Meta Introduces Celebrity Voices for Chatbot; Stellantis on the Hunt for New CEO • IH Market News • 09/24/2024 10:15:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 01:11:53 PM
- Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA) • PR Newswire (US) • 09/23/2024 11:30:00 AM
- Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia • PR Newswire (US) • 09/20/2024 11:09:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:35:34 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 08/16/2024 08:31:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:25:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/16/2024 08:21:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:06:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:17:54 PM
- Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments • PR Newswire (US) • 08/08/2024 08:05:00 PM
- Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day • PR Newswire (US) • 05/29/2024 11:30:00 AM
- Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors • PR Newswire (US) • 05/29/2024 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:42:44 PM
ILUS Announces Completion of QIND Acquisition by Fusion Fuel (NASDAQ: HTOO) • ILUS • Nov 27, 2024 12:35 PM
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer • BLO • Nov 26, 2024 8:48 AM
BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL • BQST • Nov 26, 2024 8:00 AM
BNCM Announces its Q3 and 9-Month Growth Results for 2024 • BNCM • Nov 26, 2024 7:03 AM
FoodTech Trailblazer Beyond Oil Appoints New COO from KFC Amidst Massive Global Expansion (OTCQB: BEOLF) (CSE: BOIL), up 250% this year • BOIL • Nov 25, 2024 11:12 AM
UC Asset announces plan of acquisition to increase awareness for its stock trading • UCASU • Nov 25, 2024 9:30 AM